registernow05

Programme by Interest

Hospital Pharmacy


Today, the practice of Hospital Pharmacy encompasses a wide array of roles and responsibilities, including the very important task of increasing accessibility to accurate and ethical information on medicines use and pharmacotherapy in and outside the hospital setting, including epidemics and emergency situations.

Nowadays drug information in the public domain impacts numerous aspects of medicines use and patient safety. What is the role of the pharmacist in helping patients make informed decisions based on such information? The hospital pharmacist works within the healthcare team and with patients to review medicines use and monitor the trends and outcomes of therapy. Join us in exploring the challenges faced in implementing medication reviews in healthcare, required competencies, training, impact of medication review on therapies and healthcare partnerships. A unique session will explore and reveal the use of pictograms in risk communications, and the effect such efforts have on patient safety. Antimicrobial drug resistance (AMR) as an emerging global health problem will also be addressed, as well as reports from professional organisations and a consensus of experts-outlined strategies for the control of resistance in hospitals and in the community.


* G25
ANTIMICROBIAL DRUG RESISTANCE – THE ROLE OF THE PHARMACY PROFESSION IN TACKLING THIS EMERGING GLOBAL HEALTH PROBLEM

Antimicrobial Drug Resistance (AMR) is an emerging global health problem that, if not addressed immediately and properly, may advance into one of the most significant public health challenges worldwide. Within the last few years many governmental and non-governmental bodies, such as the UK House of Lords, the EU Chief Medical Officers of Health, the WHO, the US Centers for Disease Control and Prevention (CDC) and a US Senatorial Bipartisan Committee have all indicated that AMR is a major threat to public health.

The steady increase in AMR continues despite the introduction of new antibiotics. AMR is associated with increased patient morbidity and mortality as well as with increased costs. Addressing the problem of AMR requires both infection control and regulation of antibiotic use. Reports from professional organisations and a consensus of experts have outlined strategies for the control of resistance in hospitals and in the community. However, the importance of a multidisciplinary approach in tackling the problem of AMR should be emphasised. This symposium will examine the many facets associated with AMR with an emphasis on the role of health-related professional organisations.


» full programme

* G26
RISK COMMUNICATION IN PATIENT SAFETY: TO WHAT EXTENT CAN PICTOGRAMS HELP IN LABELING?

The safe use of medicines depends on many factors, such as safe storage, safe prescribing, safe dispensing and counselling. Various techniques have been developed to support these processes in which effective risk communication has been identified as crucial part of improving patient safety. This session will focus on the role of the pharmacist in improving risk communication, especially by using pictograms. Valuable insight from projects where effective risk communication has made a significant contribution to safe and effective use of medicines will be provided.


» full programme

* G29
MEDICATION REVIEWS – FROM MEDICATION COUNSELLING TOWARDS SERVICE DELIVERY

This three-hour joint session will explore the concept and value of medication reviews as a pharmaceutical service in healthcare. Issues such as the models and status of medication reviews in different countries, the challenges faced in the implementation of medication reviews in healthcare, required competencies and training as well as the impact of medication reviews on drug therapies and healthcare partnerships will be discussed. The session is targeted at individuals and key stakeholders involved in the design and implementation of professional pharmacy and pharmaceutical services.


» full programme

* G30
GOOD VERSUS BAD DRUG INFORMATION IN THE PUBLIC DOMAIN – CAN YOU SPOT THE DIFFERENCE?
Empowering pharmacists and educating patients how to use online information

Drug information in the public domain impacts various aspects of medicines use and patient safety. The “good” information empowers the patients to become an active partner in their therapy. However, the incomplete or improper use of medication information can have dramatic effects. But how is good or bad drug information defined and what is the role of the pharmacist in helping patients to make informed decisions based on such information?

The abundance of online medication information poses new challenges for both patients and healthcare professionals. How can information be appropriate, complete, correct, and at the same time on accessible level to the patient? Can pharmacists educate patients how to use online information?

The medication information from various online sources influences also the pharmacy profession. In education various sources on Internet will influence the students’ opinions about safe and effective use of medicines. As medicines experts who can assist consumers’ medicines information needs, pharmacists need to be able learn how to search for and evaluate Internet-based information themselves.

In their practice, there is an increased demand for objective interpretation of the available medicines information. But how are professionals providing pharmaceutical care at the drug information centres influenced by publicly available drug information?


» full programme

* G31
THE USE OF INFORMATICS TO IMPROVE MEDICATION SAFETY

The safe use of medicines depends on many factors, such as safe storage, safe prescribing, safe dispensing, safe administering and counselling. Various techniques have been developed to improve and support these practices. The use of informatics has been identified as a crucial component in improving medication safety. This session will evaluate the various techniques, describe the importance of risk assessment tools, and offer some valuable insight from projects where effective use of informatics has made a significant contribution to safe use of medicines.


» full programme

* G39
RATIONALISING MEDICATION MANAGEMENT FOR EMERGENCY RESPONSE

Over the past several years pharmacists have begun to make a significant contribution to emergency response situations necessitated by both natural and man-made catastrophes. During this session the importance of pharmacists’ contribution to the theory and practice of drug donations to affected areas will be stressed, and how pharmacists are imperative for the safe and effective delivery to the ultimate destination: victims in need. In addition, representatives from the Chinese and Uruguay armed forces will advise on current medication protocols.
» full programme

* G40
RESPONDING TO GLOBAL AND LOCAL EMERGENCIES

The programme will examine the types of local and global emergencies which can occur, as well as their potential impact on practice. Using ‘real life’ examples, a critical examination of responses to emergency situations will be undertaken in order to allow participants to strengthen their ability create emergency preparedness plans. Participants will have the opportunity to examine the types of aid required during emergencies both locally and abroad, as well as understand the rationale behind current WHO guidelines for donations during emergencies.


» full programme

* G11
TRENDS IN COMMUNITY PHARMACY – DEBATING THE FUTURE OF THE PROFESSION: FORUM FOR POLICY MAKERS IN PHARMACY PRACTICE

No matter where in the world community pharmacists are practicing, issues such as pharmacist prescribing ( USA : Collaborative practice), deregulation of the pharmacy sector, leadership and succession, and the role of the pharmacist are being discussed. It is crucial to maintain an open debate within the profession, encompassing policy makers and practicing pharmacists as well as future professionals.


» full programme


* These sessions are accredited by ACPE for continuing education units. For more information on accreditation, please email congress@fip.org

I would like to register for the FIP Congress in Beijing.

Contact | Copyright © 2007 FIP all rights reserved

*/ ?>